Nanopath raised $25M (Series B)
Diagnostics company building rapid point-of-care molecular tests for women's health using plasmonic optical biosensing.
Your first lead, free
Make Nanopath your first lead, free
Their marketing gap, who to email, an email written for you and how to pitch them. Your first lead is free, one per person, and there is no card needed.
Also free: the Monday list
Every Monday, the startups that just raised, by email.
Pro, $39/mo: the same view for every company like this in your niche, every Monday. See what's in Pro
- Raised
- $25M
- Round
- Series B
- Announced
- 2 days ago
- Location
- Cambridge, MA
- Industry
- Health
Marketing gap:hidden, see with Pro
Signals
- Raised $25MAnnounced Nov 10, 2026, 2 days ago
- Series B round
- Based in Cambridge, MARegion: US
- Reported by PR NewswireAdded to the board Nov 12, 2026. Read the announcement ↗
Investors
Also backed by Norwest: Dreeze, Circuit Mind, Vitalize and 1 more
From the announcement.
More Health startups that just raised
Get the Monday list of who raised, free by email. Get the Monday list
More Series B Health startups that raised this month
Similar startups
Nanopath is on these lists of startups that just raised: